Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mula, M.
Right arrow Articles by Sander, J. W.A.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mula, M.
Right arrow Articles by Sander, J. W.A.S.
Related Collections
Right arrow All Epilepsy/Seizures
Right arrow Antiepileptic drugs

Neurology 2003;61:704-706
© 2003 American Academy of Neurology
Brief Communications

Psychiatric adverse events during levetiracetam therapy

M. Mula, MD, M. R. Trimble, MD FRCP, FRCPsych, A. Yuen, MD MRCP, R. S.N. Liu, MD MRCP and J. W.A.S. Sander, MD MRCP, PhD

From the Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London, UK.

Address correspondence and reprint requests to Dr. M.R. Trimble, Institute of Neurology, Queen Square, London WC1N 3BG, UK; e-mail: mtrimble{at}ion.ucl.ac.uk

The prevalence and psychopathologic features of psychiatric adverse events (PAE) in 517 patients taking levetiracetam (LEV) were investigated. Fifty-three (10.1%) patients developed PAE. A significant association was found with previous psychiatric history, history of febrile convulsions, and history of status epilepticus, whereas lamotrigine co-therapy had a protective effect. PAE were not related to the titration schedule of LEV, and certain patients seem to be biologically more vulnerable.




This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
M. U. Farooq, A. Bhatt, A. Majid, R. Gupta, A. Khasnis, and M. Y. Kassab
Levetiracetam for managing neurologic and psychiatric disorders
Am. J. Health Syst. Pharm., March 15, 2009; 66(6): 541 - 561.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. Z. Koubeissi, S. Amina, I. Pita, G. K. Bergey, and M. A. Werz
Tolerability and efficacy of oral loading of levetiracetam
Neurology, May 27, 2008; 70(22_Part_2): 2166 - 2170.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
F Ovsiew
Antiepileptic drugs in psychiatry
J. Neurol. Neurosurg. Psychiatry, December 1, 2004; 75(12): 1655 - 1661.
[Full Text] [PDF]

Home page
 NeurologyHome page
R. Sankar
Initial treatment of epilepsy with antiepileptic drugs: Pediatric issues
Neurology, November 23, 2004; 63(10_suppl_4): S30 - S39.
[Abstract] [Full Text]

Home page
 Postgrad. Med. J.Home page
S Beyenburg, J Bauer, and M Reuber
New drugs for the treatment of epilepsy: a practical approach
Postgrad. Med. J., October 1, 2004; 80(948): 581 - 587.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
R. Sankar and G. L. Holmes
Mechanisms of Action for the Commonly Used Antiepileptic Drugs: Relevance to Antiepileptic Drug-Associated Neurobehavioral Adverse Effects
J Child Neurol, August 1, 2004; 19(1_suppl): S6 - S14.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
T. A. Glauser
Behavioral and Psychiatric Adverse Events Associated With Antiepileptic Drugs Commonly Used in Pediatric Patients
J Child Neurol, August 1, 2004; 19(1_suppl): S25 - S38.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
A. M. Kanner and D. W. Dunn
Diagnosis and Management of Depression and Psychosis in Children and Adolescents With Epilepsy
J Child Neurol, August 1, 2004; 19(1_suppl): S65 - S72.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
R. Sankar and G. L. Holmes
Mechanisms of Action for the Commonly Used Antiepileptic Drugs: Relevance to Antiepileptic Drug--Associated Neurobehavioral Adverse Effects
J Child Neurol, January 1, 2004; 19(1_suppl): S6 - S14.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
T. A. Glauser
Behavioral and Psychiatric Adverse Events Associated With Antiepileptic Drugs Commonly Used in Pediatric Patients
J Child Neurol, January 1, 2004; 19(1_suppl): S25 - S38.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
A. M. Kanner and D. W. Dunn
Diagnosis and Management of Depression and Psychosis in Children and Adolescents With Epilepsy
J Child Neurol, January 1, 2004; 19(1_suppl): S65 - S72.
[Abstract] [PDF]